세계 1차 세포 배양 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장 및 동향 예측(2024-2032년)

The global demand for Primary Cell Culture Market is presumed to reach the market size of nearly USD 17.41 BN by 2032 from USD 5.23 BN in 2023 with a CAGR of 14.3% under the study period 2024 - 2032.

Primary cell culture involves the cultivation of cells directly extracted from living organisms, maintaining their natural environment for research and therapeutic purposes. This technique is crucial in biological and medical research, enabling scientists to study cell behavior, perform drug testing, and develop personalized medicine.

MARKET DYNAMICS

The primary cell culture market is driven by factors such as the increasing focus on personalized medicine, advancements in cell-based research, and the rising demand for cell-based therapies. These cell cultures, derived directly from living organisms, serve as valuable models for studying cellular behavior and developing novel medical treatments. The expansion of regenerative medicine and the development of targeted therapies fuel the demand for primary cell cultures in preclinical research and drug discovery. Additionally, the growing prevalence of chronic diseases and the need for more accurate in vitro models contribute to market growth. Technological innovations, including 3D cell culture systems and organoids, further enhance its relevance and utility in biomedical research. Moreover, collaborations between research institutions and biotechnology companies drive advancements in primary cell culture technologies, shaping the market's trajectory.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of primary cell culture. The growth and trends of primary cell culture industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the primary cell culture market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Primary Cells (Fat Cells, Blood Cells, Nerve Cells, Bone Cells, Endothelial Cells, Skin Cells, Muscle Cells, Stem Cells, Others)
• Reagents And Supplements (Attachment Solutions, Buffers And Salts, Sera, Growth Factors And Cytokines, Others)
• Media (Fat Cells Media, Blood Cells Media, Nerve Cells Media, Bone Cells Media, Endothelial Cells Media, Skin Cells Media, Muscle Cells Media, Stem Cells Media, Others)

By Separation Method

• Explant Method
• Enzymatic Degradation (Trypsin, Collagenase, Protease, Pronase, Dispase, Hyaluronidase, Neuraminidase, Elastase, Dnase, Papain, Accutase, Others)
• Mechanical Separation
• Others

By Type

• Animal Cells
• Human Cells

By Application

• Cell & Gene Therapy Development
• Vaccine Production
• Model System
• Virology
• Prenatal Diagnosis
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Primary Cell Culture market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Primary Cell Culture market include Merck, Thermo Fisher Scientific Inc., Danaher, Lonza, PromoCell GmbH, Corning Incorporated, Fujifilm Irvine Scientific Inc., Mattek, Axol Bioscience Ltd., ATCC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . PRIMARY CELL CULTURE - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Separation Method
  • 3.7.3 Market Attractiveness Analysis By Type
  • 3.7.4 Market Attractiveness Analysis By Application
  • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL PRIMARY CELL CULTURE MARKET ANALYSIS BY PRODUCT

• 5.1 Overview by Product
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product
• 5.4 Primary Cells (Fat Cells, Blood Cells, Nerve Cells, Bone Cells, Endothelial Cells, Skin Cells, Muscle Cells, Stem Cells, Others) Historic and Forecast Sales by Regions
• 5.5 Reagents And Supplements (Attachment Solutions, Buffers And Salts, Sera, Growth Factors And Cytokines, Others) Historic and Forecast Sales by Regions
• 5.6 Media (Fat Cells Media, Blood Cells Media, Nerve Cells Media, Bone Cells Media, Endothelial Cells Media, Skin Cells Media, Muscle Cells Media, Stem Cells Media, Others) Historic and Forecast Sales by Regions

6 . GLOBAL PRIMARY CELL CULTURE MARKET ANALYSIS BY SEPARATION METHOD

• 6.1 Overview by Separation Method
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Separation Method
• 6.4 Explant Method Historic and Forecast Sales by Regions
• 6.5 Enzymatic Degradation (Trypsin, Collagenase, Protease, Pronase, Dispase, Hyaluronidase, Neuraminidase, Elastase, Dnase, Papain, Accutase, Others) Historic and Forecast Sales by Regions
• 6.6 Mechanical Separation Historic and Forecast Sales by Regions
• 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL PRIMARY CELL CULTURE MARKET ANALYSIS BY TYPE

• 7.1 Overview by Type
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Type
• 7.4 Animal Cells Historic and Forecast Sales by Regions
• 7.5 Human Cells Historic and Forecast Sales by Regions

8 . GLOBAL PRIMARY CELL CULTURE MARKET ANALYSIS BY APPLICATION

• 8.1 Overview by Application
• 8.2 Historical and Forecast Data
• 8.3 Analysis by Application
• 8.4 Cell & Gene Therapy Development Historic and Forecast Sales by Regions
• 8.5 Vaccine Production Historic and Forecast Sales by Regions
• 8.6 Model System Historic and Forecast Sales by Regions
• 8.7 Virology Historic and Forecast Sales by Regions
• 8.8 Prenatal Diagnosis Historic and Forecast Sales by Regions
• 8.9 Others Historic and Forecast Sales by Regions

9 . GLOBAL PRIMARY CELL CULTURE MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2. North America By Segment Sales Analysis
  • 9.3.3. North America By Country Sales Analysis
  • 9.3.4. United State Sales Analysis
  • 9.3.5. Canada Sales Analysis
  • 9.3.6. Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2. Europe by Segment Sales Analysis
  • 9.4.3. Europe by Country Sales Analysis
  • 9.4.4. United Kingdom Sales Analysis
  • 9.4.5. France Sales Analysis
  • 9.4.6. Germany Sales Analysis
  • 9.4.7. Italy Sales Analysis
  • 9.4.8. Russia Sales Analysis
  • 9.4.9. Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2. Asia Pacific by Segment Sales Analysis
  • 9.5.3. Asia Pacific by Country Sales Analysis
  • 9.5.4. China Sales Analysis
  • 9.5.5. India Sales Analysis
  • 9.5.6. Japan Sales Analysis
  • 9.5.7. South Korea Sales Analysis
  • 9.5.8. Australia Sales Analysis
  • 9.5.9. South East Asia Sales Analysis
  • 9.5.10. Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2. Latin America by Segment Sales Analysis
  • 9.6.3. Latin America by Country Sales Analysis
  • 9.6.4. Brazil Sales Analysis
  • 9.6.5. Argentina Sales Analysis
  • 9.6.6. Peru Sales Analysis
  • 9.6.7. Chile Sales Analysis
  • 9.6.8. Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2. Middle East & Africa by Segment Sales Analysis
  • 9.7.3. Middle East & Africa by Country Sales Analysis
  • 9.7.4. Saudi Arabia Sales Analysis
  • 9.7.5. UAE Sales Analysis
  • 9.7.6. Israel Sales Analysis
  • 9.7.7. South Africa Sales Analysis
  • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE PRIMARY CELL CULTURE COMPANIES

• 10.1. Primary Cell Culture Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11 . COMPANY PROFILES OF PRIMARY CELL CULTURE INDUSTRY

• 11.1. Company Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Merck
  • 11.3.1. Company Overview
  • 11.3.2. Company Revenue
  • 11.3.3. Products
  • 11.3.4. Recent Developments
• 11.4. Thermo Fisher Scientific Inc.
  • 11.4.1. Company Overview
  • 11.4.2. Company Revenue
  • 11.4.3. Products
  • 11.4.4. Recent Developments
• 11.5. Danaher
  • 11.5.1. Company Overview
  • 11.5.2. Company Revenue
  • 11.5.3. Products
  • 11.5.4. Recent Developments
• 11.6. Lonza
  • 11.6.1. Company Overview
  • 11.6.2. Company Revenue
  • 11.6.3. Products
  • 11.6.4. Recent Developments
• 11.7. PromoCell GmbH
  • 11.7.1. Company Overview
  • 11.7.2. Company Revenue
  • 11.7.3. Products
  • 11.7.4. Recent Developments
• 11.8. Corning Incorporated
  • 11.8.1. Company Overview
  • 11.8.2. Company Revenue
  • 11.8.3. Products
  • 11.8.4. Recent Developments
• 11.9. Fujifilm Irvine Scientific Inc.
  • 11.9.1. Company Overview
  • 11.9.2. Company Revenue
  • 11.9.3. Products
  • 11.9.4. Recent Developments
• 11.10. Mattek
  • 11.10.1. Company Overview
  • 11.10.2. Company Revenue
  • 11.10.3. Products
  • 11.10.4. Recent Developments
• 11.11. Axol Bioscience Ltd.
  • 11.11.1. Company Overview
  • 11.11.2. Company Revenue
  • 11.11.3. Products
  • 11.11.4. Recent Developments
• 11.12. ATCC.
  • 11.12.1. Company Overview
  • 11.12.2. Company Revenue
  • 11.12.3. Products
  • 11.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies